About us Contacts Drug interactions: 390 212
Drug search by name

Lanoxin Pediatric Intravenous and Mifepristone Tablets (For Ending Early Pregnancy)

Determining the interaction of Lanoxin Pediatric Intravenous and Mifepristone Tablets (For Ending Early Pregnancy) and the possibility of their joint administration.

Check result:
Lanoxin Pediatric Intravenous <> Mifepristone Tablets (For Ending Early Pregnancy)
Relevance: 01.08.2022 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

MiFEPRIStone may increase the blood levels and effects of digoxin. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Contact your doctor if you experience nausea, vomiting, diarrhea, loss of appetite, visual disturbances (blurred vision; light halos around objects; green or yellow vision), or an abnormally fast or slow or uneven heartbeat, as these may be signs and symptoms of excessive digoxin levels. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

MONITOR: Coadministration with mifepristone may increase the plasma concentrations of digoxin. The proposed mechanism is mifepristone inhibition of P-glycoprotein-mediated intestinal efflux of digoxin. When digoxin 0.125 mg once daily was administered with mifepristone 1200 mg once daily for 10 days in study subjects, mean digoxin peak plasma concentration (Cmax) and systemic exposure (AUC) increased by approximately 1.6- and 1.4-fold, respectively, compared to administration of digoxin alone.

MANAGEMENT: Caution is advised if digoxin must be used concomitantly with mifepristone. Dosage adjustments as well as clinical and laboratory monitoring are appropriate for digoxin whenever mifepristone is added to or withdrawn from therapy. The manufacturer recommends that plasma digoxin concentration be measured after 1 to 2 weeks of concomitant use and periodically as necessary thereafter. Because mifepristone is eliminated slowly from the body, drug interactions may be observed for a prolonged period following discontinuation (approximately 2 to 3 weeks if mifepristone had been administered chronically to steady state).

References
  • "Product Information. Korlym (mifepristone)." Corcept Therapeutics Incorporated, Menlo Park, CA.
Lanoxin Pediatric Intravenous

Generic Name: digoxin

Brand name: Lanoxin, Digitek, Digox, Lanoxicaps, Cardoxin

Synonyms: Lanoxin

Mifepristone Tablets (For Ending Early Pregnancy)

Generic Name: mifepristone

Brand name: Korlym, Mifeprex

Synonyms: Mifepristone

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.